Richard Scott Struthers - Net Worth and Insider Trading

Richard Scott Struthers Net Worth

The estimated net worth of Richard Scott Struthers is at least $55 Million dollars as of 2024-05-26. Richard Scott Struthers is the President & CEO of Crinetics Pharmaceuticals Inc and owns about 1,159,290 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $55 Million. Details can be seen in Richard Scott Struthers's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard Scott Struthers has not made any transactions after 2024-05-08 and currently still holds the listed stock(s).

Transaction Summary of Richard Scott Struthers

To

Richard Scott Struthers Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Scott Struthers owns 1 companies in total, including Crinetics Pharmaceuticals Inc (CRNX) .

Click here to see the complete history of Richard Scott Struthers’s form 4 insider trades.

Insider Ownership Summary of Richard Scott Struthers

Ticker Comapny Transaction Date Type of Owner
CRNX Crinetics Pharmaceuticals Inc 2024-05-08 director & See Remarks

Richard Scott Struthers Latest Holdings Summary

Richard Scott Struthers currently owns a total of 1 stock. Richard Scott Struthers owns 1,159,290 shares of Crinetics Pharmaceuticals Inc (CRNX) as of May 8, 2024, with a value of $55 Million.

Latest Holdings of Richard Scott Struthers

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRNX Crinetics Pharmaceuticals Inc 2024-05-08 1,159,290 47.47 55,031,496

Holding Weightings of Richard Scott Struthers


Richard Scott Struthers Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Scott Struthers has made a total of 10 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 1 buys and 9 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 107,448 shares on May 8, 2024, which brought Richard Scott Struthers around $5 Million.

Insider Trading History of Richard Scott Struthers

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Scott Struthers Trading Performance

GuruFocus tracks the stock performance after each of Richard Scott Struthers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Scott Struthers is 19.17%. GuruFocus also compares Richard Scott Struthers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Scott Struthers within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Richard Scott Struthers's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Richard Scott Struthers

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.21
Relative Return to S&P 500(%) 5.77

Richard Scott Struthers Ownership Network

Ownership Network List of Richard Scott Struthers

No Data

Ownership Network Relation of Richard Scott Struthers


Richard Scott Struthers Owned Company Details

What does Crinetics Pharmaceuticals Inc do?

Who are the key executives at Crinetics Pharmaceuticals Inc?

Richard Scott Struthers is the director & See Remarks of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include Chief Scientific Officer Stephen F. Betz , Chief Development Officer Dana Pizzuti , and Chief Operating Officer Jeff E. Knight .

Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary

Over the past 18 months, Richard Scott Struthers made 5 insider transaction in Crinetics Pharmaceuticals Inc (CRNX) with a net sale of 448,399. Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 38,840 shares made by Stephen F. Betz , a net sale of 61,634 shares made by Dana Pizzuti , and a net sale of 57,864 shares made by Marc Wilson .

In summary, during the past 3 months, insiders sold 297,664 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 297,664 shares. During the past 18 months, 723,596 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 718,596 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Crinetics Pharmaceuticals Inc Insider Transactions

No Available Data

Richard Scott Struthers Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Scott Struthers. You might contact Richard Scott Struthers via mailing address: C/o Crinetics Pharmaceuticals, Inc., 10222 Barnes Canyon Road, Bldg. #2, San Diego Ca 92121.

Discussions on Richard Scott Struthers

No discussions yet.